These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 11082839)
21. Buccoadhesive gels of glibenclamide: a means for achieving enhanced bioavailability. Philip AK; Srivastava M; Pathak K Drug Deliv; 2009 Oct; 16(7):405-15. PubMed ID: 19624249 [TBL] [Abstract][Full Text] [Related]
22. Carbamazepine transbuccal delivery: the histo-morphological features of reconstituted human oral epithelium and buccal porcine mucosae in the transmucosal permeation. Campisi G; Paderni C; Saccone R; Siragusa MG; Lo Muzio L; Tripodo C; Giannola LI; Florena AM Int J Immunopathol Pharmacol; 2008; 21(4):903-10. PubMed ID: 19144275 [TBL] [Abstract][Full Text] [Related]
23. Oral sustained-release bioadhesive tablet formulation of didanosine. Betageri GV; Deshmukh DV; Gupta RB Drug Dev Ind Pharm; 2001 Feb; 27(2):129-36. PubMed ID: 11266224 [TBL] [Abstract][Full Text] [Related]
24. Development of novel bioadhesive buccal formulation of diltiazem: in vitro and in vivo characterization. Shayeda ; Gannu R; Palem CR; Rao YM PDA J Pharm Sci Technol; 2009; 63(5):401-8. PubMed ID: 20158046 [TBL] [Abstract][Full Text] [Related]
25. A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: design, in vitro and 'in vivo' evaluation. Wang L; Tang X Int J Pharm; 2008 Feb; 350(1-2):181-7. PubMed ID: 17920795 [TBL] [Abstract][Full Text] [Related]
26. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation. McConville JT; Ross AC; Chambers AR; Smith G; Florence AJ; Stevens HN Eur J Pharm Biopharm; 2004 May; 57(3):541-9. PubMed ID: 15093604 [TBL] [Abstract][Full Text] [Related]
27. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies. Gavini E; Hegge AB; Rassu G; Sanna V; Testa C; Pirisino G; Karlsen J; Giunchedi P Int J Pharm; 2006 Jan; 307(1):9-15. PubMed ID: 16257156 [TBL] [Abstract][Full Text] [Related]
28. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets]. Vostalová L; Rabisková M; Medvecká G Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of khaya gum as a directly compressible matrix system for controlled release. Odeku OA; Fell JT J Pharm Pharmacol; 2004 Nov; 56(11):1365-70. PubMed ID: 15525442 [TBL] [Abstract][Full Text] [Related]
30. Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation. Filipović-Grcić J; Perissutti B; Moneghini M; Voinovich D; Martinac A; Jalsenjak I J Pharm Pharmacol; 2003 Jul; 55(7):921-31. PubMed ID: 12906749 [TBL] [Abstract][Full Text] [Related]
31. Discriminatory dissolution method for quality control measurements of carbamazepine immediate release tablets based on in vitro--in vivo investigations. Xu C; Zou M; Wang Y; Liu Y; Yan J; Wu Y; Cheng G Drug Dev Ind Pharm; 2012 Jun; 38(6):679-88. PubMed ID: 21988132 [TBL] [Abstract][Full Text] [Related]
32. Formulation and in vivo evaluation of omeprazole buccal adhesive tablet. Choi H; Jung J; Yong CS; Rhee C; Lee M; Han J; Park K; Kim C J Control Release; 2000 Sep; 68(3):405-12. PubMed ID: 10974394 [TBL] [Abstract][Full Text] [Related]
33. Development and evaluation of a buccoadhesive propranolol tablet formulation. Celebi N; Kişlal O Pharmazie; 1995 Jul; 50(7):470-2. PubMed ID: 7675890 [TBL] [Abstract][Full Text] [Related]
34. Biopharmaceutical characterization of carbamazepine immediate release tablets. In vitro-in vivo comparison. Homsek I; Parojcic J; Cvetkovic N; Popadic D; Djuric Z Arzneimittelforschung; 2007; 57(8):511-6. PubMed ID: 17915636 [TBL] [Abstract][Full Text] [Related]
35. Provesicular granisetron hydrochloride buccal formulations: in vitro evaluation and preliminary investigation of in vivo performance. Ahmed S; El-Setouhy DA; El-Latif Badawi AA; El-Nabarawi MA Eur J Pharm Sci; 2014 Aug; 60():10-23. PubMed ID: 24793896 [TBL] [Abstract][Full Text] [Related]
36. Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. Brewster ME; Anderson WR; Meinsma D; Moreno D; Webb AI; Pablo L; Estes KS; Derendorf H; Bodor N; Sawchuk R; Cheung B; Pop E J Pharm Sci; 1997 Mar; 86(3):335-9. PubMed ID: 9050802 [TBL] [Abstract][Full Text] [Related]
37. Development and in vitro evaluation of buccoadhesive tablets using a new model substrate for bioadhesion measures: the eggshell membrane. Parodi B; Russo E; Gatti P; Cafaggi S; Bignardi G Drug Dev Ind Pharm; 1999 Mar; 25(3):289-95. PubMed ID: 10071821 [TBL] [Abstract][Full Text] [Related]
38. Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design. Giannola LI; De Caro V; Giandalia G; Siragusa MG; Tripodo C; Florena AM; Campisi G Eur J Pharm Biopharm; 2007 Sep; 67(2):425-33. PubMed ID: 17451927 [TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo evaluation of a novel mucoadhesive buccal oxytocin tablet prepared with Dillenia indica fruit mucilage. Metia PK; Bandyopadhyay AK Pharmazie; 2008 Apr; 63(4):270-4. PubMed ID: 18468385 [TBL] [Abstract][Full Text] [Related]
40. Development and in vitro evaluation of buccoadhesive carvedilol tablets. Yamsani VV; Gannu R; Kolli C; Rao ME; Yamsani MR Acta Pharm; 2007 Jun; 57(2):185-97. PubMed ID: 17507315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]